| Determinants of health-related quality of life in HIV-infected patients R Murri, M Fantoni, C Del Borgo, R Visona, A Barracco, A Zambelli, ... AIDS care 15 (4), 581-590, 2003 | 177 | 2003 |
| IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country V Vanini, E Petruccioli, C Gioia, G Cuzzi, N Orchi, A Rianda, L Alba, ... Journal of infection 65 (1), 49-59, 2012 | 83 | 2012 |
| The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis P Scognamiglio, G Chiaradia, G De Carli, M Giuliani, CM Mastroianni, ... BMC infectious diseases 13, 1-10, 2013 | 73 | 2013 |
| Ageing with HIV: newly diagnosed older adults in Italy N Orchi, R Balzano, P Scognamiglio, A Navarra, G De Carli, P Elia, ... Aids Care 20 (4), 419-425, 2008 | 66 | 2008 |
| Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies M Selleri, N Orchi, MS Zaniratti, R Bellagamba, A Corpolongo, C Angeletti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (2), 145-150, 2007 | 46 | 2007 |
| Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs C Alteri, V Svicher, C Gori, R D'Arrigo, M Ciccozzi, ... BMC Infectious Diseases 9, 1-11, 2009 | 41 | 2009 |
| Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors R Murri, M Fantoni, C Del Borgo, I Izzi, R Visonà, F Suter, MC Banfi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 22 (5), 461-466, 1999 | 37 | 1999 |
| Metabolic and morphologic disorders in patients treated with highly active antiretroviral therapy since primary HIV infection P Narciso, V Tozzi, G D'OFFIZI, G de Carli, N Orchi, V Galati, L Vincenzi, ... Annals of the New York Academy of Sciences 946 (1), 214-222, 2001 | 25 | 2001 |
| Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis. V Puro, G De Carli, N Orchi, L Palvarini, A Chiodera, M Fantoni, ... Journal of Biological Regulators and Homeostatic Agents 15 (3), 238-242, 2001 | 25 | 2001 |
| Recent transmission clustering of HIV-1 C and CRF17_BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy L Fabeni, C Alteri, N Orchi, C Gori, A Bertoli, F Forbici, F Montella, ... PLoS One 10 (8), e0135325, 2015 | 24 | 2015 |
| ‘Sentinel’mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing C Alteri, MM Santoro, I Abbate, G Rozera, A Bruselles, B Bartolini, C Gori, ... Journal of antimicrobial chemotherapy 66 (11), 2615-2623, 2011 | 22 | 2011 |
| Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14 L Fabeni, C Alteri, D Di Carlo, N Orchi, L Carioti, A Bertoli, C Gori, ... Journal of Antimicrobial Chemotherapy 72 (10), 2837-2845, 2017 | 21 | 2017 |
| Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical … D Goletti, A Navarra, E Petruccioli, C Cimaglia, M Compagno, G Cuzzi, ... International Journal of Infectious Diseases 92, 62-68, 2020 | 20 | 2020 |
| Antiretroviral treatment‐based cost saving interventions may offset expenses for new patients and earlier treatment start C Angeletti, P Pezzotti, A Antinori, A Mammone, A Navarra, N Orchi, ... HIV medicine 15 (3), 165-174, 2014 | 20 | 2014 |
| Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: a multicenter study V Bordoni, B Brando, P Piselli, O Forini, FE Perna, U Atripaldi, S Carputo, ... PLoS One 14 (12), e0225415, 2019 | 18 | 2019 |
| HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy A Mammone, P Pezzotti, C Angeletti, N Orchi, A Carboni, A Navarra, ... BMC infectious diseases 12, 1-10, 2012 | 17 | 2012 |
| Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy L Fabeni, C Alteri, G Berno, R Scutari, N Orchi, G De Carli, A Bertoli, ... Sexually Transmitted Infections 95 (8), 619-625, 2019 | 14 | 2019 |
| Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis I Abbate, C Pergola, M Pisciotta, R Sciamanna, C Sias, N Orchi, ... Journal of Clinical Virology 61 (1), 166-169, 2014 | 12 | 2014 |
| Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen C Alteri, A Artese, G Beheydt, MM Santoro, G Costa, L Parrotta, A Bertoli, ... Journal of Antimicrobial Chemotherapy 68 (10), 2205-2209, 2013 | 12 | 2013 |
| Early discharge of infectious disease patients: an opportunity or extra cost for the Italian healthcare system F Palmieri, F Alberici, A Deales, G Furneri, F Menichetti, N Orchi, ... Infez Med 21 (4), 270-278, 2013 | 10 | 2013 |
